ANAVEX LIFE SCIENCES CORP. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001731122-25-001105
- Form type
- 10-Q
- CIK
- 0001314052
- Primary document
- https://www.sec.gov/Archives/edgar/data/1314052/000173112225001105/e6751_10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANAVEX LIFE SCIENCES CORP..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-40.6M | - | - |
| Net Income | $-36.5M | - | - |
| Eps Basic | -0.43 | - | - |
| Eps Diluted | -0.43 | - | - |
| Cash And Equivalents | $101.2M | - | - |
| Total Assets | $102.4M | - | - |
| Total Liabilities | $11.5M | - | - |
| Shareholders Equity | $91.0M | - | - |
| Operating Cash Flow | $-30.4M | - | - |